Immune Checkpoint Blockers Linked to Rare Blood Platelet Disorder in Two Global Drug Safety Databases
A pharmacovigilance analysis of US and Japanese adverse event databases finds that PD-1 and PD-L1 checkpoint inhibitors show a robust, ...
Tag: PD-L1 inhibitors
Surufatinib Plus Immunotherapy Shows Promise as Maintenance Therapy for Aggressive Lung Cancer
A phase 2a trial found that surufatinib combined with PD-1/PD-L1 inhibitors as first-line maintenance therapy yielded a median progression-free survival ...
PD-L1 inhibitor BMS-1 injures keratinocytes: network toxicology reveals mechanisms
Immunotherapy has rewritten the prognosis for lung cancer, yet one of its most persistent costs is written on the skin. ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!